ALBANY, N.Y., May 09, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C. Greiner, Executive Vice President and Chief Financial Officer, is scheduled to present at the 2017 UBS Global Healthcare Conference on Monday, May 22, 2017, at 8:30 a.m. ET. The conference will be held at the Grand Hyatt in New York.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' session may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral
vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
News Provided by Acquire Media